Fatal toxic epidermal necrolysis after griseofulvin. 1989

G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006118 Griseofulvin An antifungal agent used in the treatment of TINEA infections. Fulvicin-U-F,Grifulvin V,Gris-PEG,Grisactin,Grisefuline,Fulvicin U F,FulvicinUF,Gris PEG,GrisPEG
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013262 Stevens-Johnson Syndrome Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis. Drug-Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndrome,Epidermal Necrolysis, Toxic,Lyell's Syndrome,Mycoplasma-Induced Stevens Johnson Syndrome,Mycoplasma-Induced Stevens-Johnson Syndrome,Nonstaphylococcal Scalded Skin Syndrome,Scalded Skin Syndrome, Nonstaphylococcal,Stevens Johnson Syndrome Toxic Epidermal Necrolysis,Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Toxic Epidermal Necrolysis,Toxic Epidermal Necrolysis Stevens Johnson Syndrome,Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum,Drug Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndromes,Epidermal Necrolyses, Toxic,Lyell Syndrome,Lyell's Syndromes,Mycoplasma Induced Stevens Johnson Syndrome,Necrolyses, Toxic Epidermal,Necrolysis, Toxic Epidermal,Stevens Johnson Syndrome,Stevens-Johnson Syndrome, Drug-Induced,Stevens-Johnson Syndrome, Mycoplasma-Induced,Stevens-Johnson Syndromes, Drug-Induced,Syndrome, Lyell's,Syndrome, Mycoplasma-Induced Stevens-Johnson,Syndromes, Lyell's,Toxic Epidermal Necrolyses

Related Publications

G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
September 1988, Journal of the American Academy of Dermatology,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
June 2005, The Annals of pharmacotherapy,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
January 1991, European journal of cancer (Oxford, England : 1990),
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
February 1992, BMJ (Clinical research ed.),
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
November 2004, Clinical and experimental dermatology,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
January 2006, Clinical and experimental dermatology,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
July 2001, Clinical and experimental dermatology,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
January 2001, Therapie,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
April 2009, Pharmacotherapy,
G Mion, and R Verdon, and Y Le Gulluche, and H Carsin, and A Garcia, and J Guilbaud
July 1974, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!